OLBA HEALTHCARE HOLDINGS Management

Management criteria checks 2/4

OLBA HEALTHCARE HOLDINGS' CEO is Yohei Maeshima, appointed in Sep 2021, has a tenure of 2.67 years. directly owns 16.84% of the company’s shares, worth ¥2.01B. The average tenure of the management team and the board of directors is 4.7 years and 6 years respectively.

Key information

Yohei Maeshima

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	2.7yrs
CEO ownership	16.8%
Management average tenure	4.7yrs
Board average tenure	6yrs

Recent management updates

Recent updates

OLBA HEALTHCARE HOLDINGS (TSE:2689) Is Due To Pay A Dividend Of ¥70.00

Apr 25

CEO

Yohei Maeshima (56 yo)

2.7yrs

Tenure

Mr. Yohei Maeshima serves as Chief Executive Officer at OLBA HEALTHCARE HOLDINGS, Inc. since September 2021 and serves as its Chairman. He has been the President and Representative Director of OLBA HEALTHC...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Yohei Maeshima	Chairman	2.7yrs	no data	16.84% ¥ 2.0b
Katsuyuki Kuwamura	MD, GM of Sales Headquarters & Director	1.7yrs	no data	0.068% ¥ 8.1m
Kyousuke Isoda	Senior MD	10.7yrs	no data	0.10% ¥ 12.1m
Nobuharu Murata	MD, Head of Management Headquarters & Director	6.7yrs	no data	0.17% ¥ 20.2m
Midori Matsui	Internal Audit Office Manager	no data	no data	no data

4.7yrs

Average Tenure

49yo

Average Age

Experienced Management: 2689's management team is considered experienced (4.7 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Yohei Maeshima	Chairman	9.7yrs	no data	16.84% ¥ 2.0b
Katsuyuki Kuwamura	MD, GM of Sales Headquarters & Director	3.7yrs	no data	0.068% ¥ 8.1m
Kyousuke Isoda	Senior MD	10.7yrs	no data	0.10% ¥ 12.1m
Nobuharu Murata	MD, Head of Management Headquarters & Director	10.7yrs	no data	0.17% ¥ 20.2m
Teruhiko Hattori	Independent Outside Director	7.7yrs	no data	no data
Junnichi Moriya	Outside Corporate Auditor	6.7yrs	no data	no data
Yukiko Kawamoto	Independent Outside Director	5.3yrs	no data	0.017% ¥ 2.0m
Hidenari Shuto	Outside Auditor	5.3yrs	no data	no data
Yukihiro Kitagawa	Independent Outside Director	3.7yrs	no data	no data
Tohei Nitta	Outside Audit & Supervisory Board Member	2.7yrs	no data	no data

6.0yrs

Average Tenure

58yo

Average Age

Experienced Board: 2689's board of directors are considered experienced (6 years average tenure).

OLBA HEALTHCARE HOLDINGS Management

Management criteria checks 2/4

Key information

Recent management updates

OLBA HEALTHCARE HOLDINGS, Inc., Annual General Meeting, Sep 28, 2023

Less than half of directors are independent

OLBA HEALTHCARE HOLDINGS, Inc., Annual General Meeting, Sep 21, 2022

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: JP¥106 (vs JP¥80.65 in 3Q 2023)

OLBA HEALTHCARE HOLDINGS (TSE:2689) Is Due To Pay A Dividend Of ¥70.00

OLBA HEALTHCARE HOLDINGS, Inc. to Report Q3, 2024 Results on Apr 30, 2024

Second quarter 2024 earnings released: EPS: JP¥53.29 (vs JP¥49.21 in 2Q 2023)

Olba Healthcare Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 30, 2024

OLBA HEALTHCARE HOLDINGS, Inc. to Report Q2, 2024 Results on Jan 31, 2024

First quarter 2024 earnings released: EPS: JP¥27.84 (vs JP¥41.76 in 1Q 2023)

OLBA HEALTHCARE HOLDINGS, Inc. (TSE:2689) announces an Equity Buyback for 120,000 shares, representing 1.99% for ¥221.4 million.

OLBA HEALTHCARE HOLDINGS, Inc. to Report Q1, 2024 Results on Oct 31, 2023

New major risk - Earnings quality

Full year 2023 earnings released: EPS: JP¥235 (vs JP¥253 in FY 2022)

OLBA HEALTHCARE HOLDINGS, Inc., Annual General Meeting, Sep 28, 2023

Upcoming dividend of JP¥70.00 per share at 3.0% yield

OLBA HEALTHCARE HOLDINGS, Inc. to Report Fiscal Year 2023 Results on Aug 09, 2023

Third quarter 2023 earnings released: EPS: JP¥80.65 (vs JP¥98.75 in 3Q 2022)

OLBA HEALTHCARE HOLDINGS, Inc. Provides Dividend Guidance for the Fiscal Year Ending June 30, 2023

Second quarter 2023 earnings released: EPS: JP¥49.21 (vs JP¥58.66 in 2Q 2022)

OLBA HEALTHCARE HOLDINGS, Inc. to Report Q2, 2023 Results on Jan 31, 2023

First quarter 2023 earnings released: EPS: JP¥41.76 (vs JP¥28.77 in 1Q 2022)

Less than half of directors are independent

First quarter 2023 earnings released: EPS: JP¥41.76 (vs JP¥28.77 in 1Q 2022)

Olba Healthcare Holdings, Inc. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending June 30, 2023

OLBA HEALTHCARE HOLDINGS, Inc. to Report Q1, 2023 Results on Oct 31, 2022

OLBA HEALTHCARE HOLDINGS, Inc. Announces Dividend for the Year Ended June 30, 2022, Payable on September 22, 2022

Full year 2022 earnings released: EPS: JP¥253 (vs JP¥163 in FY 2021)

OLBA HEALTHCARE HOLDINGS, Inc., Annual General Meeting, Sep 21, 2022

Upcoming dividend of JP¥60.00 per share

OLBA HEALTHCARE HOLDINGS, Inc. to Report Fiscal Year 2022 Results on Aug 09, 2022

Third quarter 2022 earnings released: EPS: JP¥98.75 (vs JP¥81.22 in 3Q 2021)

Less than half of directors are independent

OLBA HEALTHCARE HOLDINGS, Inc. to Report Q3, 2022 Results on Apr 28, 2022

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Olba Healthcare Holdings, Inc. Provides Year End Dividend Guidance for the Year Ending June 30, 2022

Full year 2021 earnings released: EPS JP¥163 (vs JP¥56.69 in FY 2020)

Upcoming dividend of JP¥45.00 per share

Third quarter 2021 earnings released: EPS JP¥81.22 (vs JP¥50.60 in 3Q 2020)

Third quarter 2021 earnings released: EPS JP¥81.22 (vs JP¥50.60 in 3Q 2020)

New 90-day high: JP¥1,629

OLBA HEALTHCARE HOLDINGS, Inc. to Report Q3, 2021 Results on Apr 30, 2021

Second quarter 2021 earnings released: EPS JP¥55.08 (vs JP¥13.19 loss in 2Q 2020)

New 90-day high: JP¥1,527

Second quarter 2021 earnings released: EPS JP¥55.08 (vs JP¥13.19 loss in 2Q 2020)

New 90-day high: JP¥1,467

New 90-day high: JP¥1,460

Kawanishi Holdings, Inc. to Report Q1, 2021 Results on Nov 02, 2020

CEO

Tenure

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age